When CML Therapy Shifts: Collaborative Approaches to Treatment Changes

Opinion
Video

Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.

Recent Videos
A 2-way communication between providers and patients may help facilitate dose modifications to help better manage adverse effects.
Treatment with AML depends on a variety of factors, including stage of treatment, transplant eligibility, and mutational status.
The medical characteristics of a patient may heavily factor into the selection of tyrosine kinase inhibition for the treatment of chronic myeloid leukemia.
The toxicity profile of interferon and the limited availability of transplantation established a need for TKI development for chronic myeloid leukemia.
4 experts in this video
4 experts in this video
4 experts in this video